Cargando…

Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19

Introduction  Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods  Retrospective observational cohort w...

Descripción completa

Detalles Bibliográficos
Autores principales: Paz Rios, Luis H., Minga, Iva, Kwak, Esther, Najib, Ayman, Aller, Ashley, Lees, Elizabeth, Macrinici, Victor, Rezaei Bookani, Kaveh, Pursnani, Amit, Caprini, Joseph, Spyropoulos, Alex C., Tafur, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219405/
https://www.ncbi.nlm.nih.gov/pubmed/34179684
http://dx.doi.org/10.1055/s-0041-1730293
_version_ 1783710919404027904
author Paz Rios, Luis H.
Minga, Iva
Kwak, Esther
Najib, Ayman
Aller, Ashley
Lees, Elizabeth
Macrinici, Victor
Rezaei Bookani, Kaveh
Pursnani, Amit
Caprini, Joseph
Spyropoulos, Alex C.
Tafur, Alfonso
author_facet Paz Rios, Luis H.
Minga, Iva
Kwak, Esther
Najib, Ayman
Aller, Ashley
Lees, Elizabeth
Macrinici, Victor
Rezaei Bookani, Kaveh
Pursnani, Amit
Caprini, Joseph
Spyropoulos, Alex C.
Tafur, Alfonso
author_sort Paz Rios, Luis H.
collection PubMed
description Introduction  Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods  Retrospective observational cohort with severe COVID-19 performed in NorthShore University Health System. Patients were >18 years of age and met criteria for inpatient or intensive care unit (ICU) care. The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) and Caprini scores were calculated and patients were stratified. Results  This study includes 184 patients, mostly men (63.6%), Caucasian (54.3%), 63 years old (interquartile range [IQR]: 24–101), and 57.1% of them required ICU care. Twenty-seven (14.7%) thrombotic events occurred: 12 (6.5%) cases of disseminated intravascular coagulation (DIC), 9 (4.9%) of pulmonary embolism, 5 (2.7%) of deep vein thrombosis, and 1 (0.5%) stroke. Among them, 86 patients (46.7%) died, 95 (51.6%) were discharged, and 3 (1.6%) were still hospitalized. “Moderate risk for VTE” and “High risk for VTE” by IMPROVE score had significant mortality association: (hazard ratio [HR]: 5.68; 95% confidence interval [CI]: 2.93–11.03; p  < 0.001) and (HR = 6.22; 95% CI: 3.04–12.71; p  < 0.001), respectively, with 87% sensitivity and 63% specificity (area under the curve [AUC] = 0.752, p  < 0.001). “High Risk for VTE” by Caprini score had significant mortality association (HR = 17.6; 95% CI: 5.56–55.96; p  < 0.001) with 96% sensitivity and 55% specificity (AUC = 0.843, p  < 0.001). Both scores were associated with thrombotic events when classified as “High risk for VTE” by IMPROVE (HR = 6.50; 95% CI: 2.72–15.53; p  < 0.001) and Caprini scores (HR = 11.507; 95% CI: 2.697–49.104; p  = 0.001). Conclusion  The IMPROVE and Caprini risk scores were independent predictors of mortality and thrombotic events in severe COVID-19. With larger validation, this can be useful prognostic information.
format Online
Article
Text
id pubmed-8219405
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-82194052021-06-24 Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 Paz Rios, Luis H. Minga, Iva Kwak, Esther Najib, Ayman Aller, Ashley Lees, Elizabeth Macrinici, Victor Rezaei Bookani, Kaveh Pursnani, Amit Caprini, Joseph Spyropoulos, Alex C. Tafur, Alfonso TH Open Introduction  Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods  Retrospective observational cohort with severe COVID-19 performed in NorthShore University Health System. Patients were >18 years of age and met criteria for inpatient or intensive care unit (ICU) care. The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) and Caprini scores were calculated and patients were stratified. Results  This study includes 184 patients, mostly men (63.6%), Caucasian (54.3%), 63 years old (interquartile range [IQR]: 24–101), and 57.1% of them required ICU care. Twenty-seven (14.7%) thrombotic events occurred: 12 (6.5%) cases of disseminated intravascular coagulation (DIC), 9 (4.9%) of pulmonary embolism, 5 (2.7%) of deep vein thrombosis, and 1 (0.5%) stroke. Among them, 86 patients (46.7%) died, 95 (51.6%) were discharged, and 3 (1.6%) were still hospitalized. “Moderate risk for VTE” and “High risk for VTE” by IMPROVE score had significant mortality association: (hazard ratio [HR]: 5.68; 95% confidence interval [CI]: 2.93–11.03; p  < 0.001) and (HR = 6.22; 95% CI: 3.04–12.71; p  < 0.001), respectively, with 87% sensitivity and 63% specificity (area under the curve [AUC] = 0.752, p  < 0.001). “High Risk for VTE” by Caprini score had significant mortality association (HR = 17.6; 95% CI: 5.56–55.96; p  < 0.001) with 96% sensitivity and 55% specificity (AUC = 0.843, p  < 0.001). Both scores were associated with thrombotic events when classified as “High risk for VTE” by IMPROVE (HR = 6.50; 95% CI: 2.72–15.53; p  < 0.001) and Caprini scores (HR = 11.507; 95% CI: 2.697–49.104; p  = 0.001). Conclusion  The IMPROVE and Caprini risk scores were independent predictors of mortality and thrombotic events in severe COVID-19. With larger validation, this can be useful prognostic information. Georg Thieme Verlag KG 2021-06-22 /pmc/articles/PMC8219405/ /pubmed/34179684 http://dx.doi.org/10.1055/s-0041-1730293 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Paz Rios, Luis H.
Minga, Iva
Kwak, Esther
Najib, Ayman
Aller, Ashley
Lees, Elizabeth
Macrinici, Victor
Rezaei Bookani, Kaveh
Pursnani, Amit
Caprini, Joseph
Spyropoulos, Alex C.
Tafur, Alfonso
Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title_full Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title_fullStr Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title_full_unstemmed Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title_short Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
title_sort prognostic value of venous thromboembolism risk assessment models in patients with severe covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219405/
https://www.ncbi.nlm.nih.gov/pubmed/34179684
http://dx.doi.org/10.1055/s-0041-1730293
work_keys_str_mv AT pazriosluish prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT mingaiva prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT kwakesther prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT najibayman prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT allerashley prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT leeselizabeth prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT macrinicivictor prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT rezaeibookanikaveh prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT pursnaniamit prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT caprinijoseph prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT spyropoulosalexc prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19
AT tafuralfonso prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19